The size of the transplant diagnostics market will grow at an 8% CAGR

Pune, November 14, 2022 (GLOBE NEWSWIRE) – According to the latest report published by Growth Plus Reports, the Transplant diagnostics market stopwatch $ 1.98 billion by 2030. The rapidly growing adoption of digitization due to increasing urbanization is an important factor for the transplant diagnostics market. This exclusive information is published by Growth Plus Reports in its report entitled “Transplant Diagnostics Market – Global Outlook & Forecast 2022-2030

Get a sample PDF brochure:

Market driver

As the prevalence of chronic diseases that could cause organ failure increases, the adoption of transplant diagnostics (including both pre- and post-transplant screening) is expected to increase significantly. Due to the multiple benefits these tests offer to determine the feasibility of the organ transplant procedure, the market has attracted the attention of healthcare professionals. Organ transplant management now has access to better diagnostic alternatives thanks to important technological innovations in transplant diagnostics. The market is mature in industrialized countries, however there are potential markets for transplant diagnostics in developing countries such as LAMEA and Asia-Pacific. Furthermore, the increase in the geriatric population, the increasing prevalence of chronic diseases, the increase in laboratory automation of robot-assisted diagnostic procedures, and technological advances in human leukocyte antigen typing are some of the key factors driving global growth. stem cell, soft tissue and solid transplant markets.

Excerpts from “Segmentation by type”

Based on the type of transplant, the transplant diagnostics market has been segmented

  • Solid organ
  • Stem cell
  • Soft fabric

The solid organ transplant segment dominated the segment during the forecast period. Over the projected period, the solid organ transplant segment is expected to contain a significant share. Since its inception as an experimental procedure in the 20th century, solid organ transplantation is now recognized as a well-recognized and useful therapeutic option for patients with end-stage organ disease. The kidneys are the organ that receives the most transplants, followed by the liver. In February 2022, the Health Resources and Services Administration reported that there were over 106,000 people on the U.S. national transplant waiting list for solid organ transplants. The kidney (83%) is the organ with the longest waiting time, followed by the liver (11%), pancreas (1%), heart (3%) and others (2%). Increased testing is required for transplants due to increased demand for solid organs, which should stimulate segment growth during the forecast period. The expansion of this market will also be driven by the increasing adoption of organ transplant tests, which is another factor. For example, Prospera with quantification, a cell-free DNA (cfDNA) test for kidney rejection, was introduced by Natera Inc. in September 2021. Natera Inc. is a major player in the transformation of healthcare through genetic testing and cfDNA.

Excerpts from “Segmentation by region”

Based on the region, the transplant diagnostics market has been segmented

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

The transplant diagnostics market is expected to be dominated by North America and this trend is expected to continue throughout the projected period. Countries in the region, including the United States and Canada, are well equipped with infrastructure, sponsored organizations, and government involvement to encourage organ transplantation for patients. For example, the National Institute of Health reported in May 2022 that the projected budget for transplant research in 2020, 2021 and 2022 was $ 721 million, $ 702 million and $ 735 million. Greater adoption of transplant diagnostics and market growth in this region will result from increased funding for transplant research. In addition, more than 40,000 organ transplants occurred in the United States in 2021, according to the Organ Donation Statistics report published in February 2022. Thus, over the course of the projection period, the increase in transplants will fuel the expansion of the market.

Excerpts from “Competitive Landscape”

Some of the major players in the global transplant diagnostics market include

  • Thermo Fisher Scientific, Inc.
  • Link Biosciences
  • Illumina, Inc.
  • F. Hoffmann La-Roche Ag.
  • Abbott Laboratories, Inc.
  • Qiagen NV
  • Sigma-Aldrich
  • Immucor Transplant Diagnostics, Inc.
  • Biomérieux Sa
  • Bio-Rad Laboratories, Inc.
  • Affymetrix, Inc.
  • Omixon Ltd.

Inquire before purchasing this research report:

Table of contents

    1. Market ecosystem
    2. Chronology under consideration
      1. Historical years – 2020
      2. Base year – 2021
      3. Estimated years: from 2022 to 2030
    3. Currency used in the report
    1. Research approach
    2. Data collection methodology
    3. Origin of the data
      1. Secondary sources
      2. Primary sources
    4. Approach to market estimation
      1. Bottom up
      2. From top to bottom
    5. Market forecasting model
    6. Limitations and assumptions
    1. Current market trends (COVID-19 perspective)
    2. Key Players and Competitive Positioning (2021)
    1. Drivers
    2. Restrictions / Challenges
    3. Chance
    1. Probiotic supplements
    2. Herbal supplements
    3. Vitamin and mineral supplements
      1. Vitamin C supplements
      2. Vitamin D supplements
      3. Vitamin B complex supplements
      4. Multivitamins
      5. Selenium supplements
      6. Zinc supplements
      7. Other
    4. Other
    1. Gut health
    2. Hair growth
    3. Respiratory tract infection
    4. Other
    1. Capsules
    2. Gel
    3. Jelly
    4. Tablets
    5. Dust
    6. Liquid
    7. Other

TOC Continue …


  • Fueled with hours of free analysis and expert interviews with each report
  • Comprehensive quantitative and qualitative insights at segment and subsegment level
  • Trends and prospects for the impact of Covid 19
  • Granular insights at the global / regional / country level
  • Insights rooted in market dynamics (driving factors, constraints, opportunities) and on the business environment
  • Global coverage of the competitive landscape
  • Winning imperatives
  • Comprehensive coverage of the ‘Strategic Developments’ recorded by the main market players


  • Assessment of the distributor’s landscape
  • Evaluation of the pipeline
  • Price intelligence
  • Customer base evaluation
  • Investments and initiatives analysis
  • ‘Company profile’ of key players

Buy Now Full Report:

Who we are

Growth + Reports is part of GRG Health, a global health knowledge services company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

The Growth + service portfolio builds on our core capabilities in secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and revolutionary solutions that prepare them for future growth and success.

We have been awarded by prestigious CEO Magazine as the “Most Innovative Healthcare Market Research Firm of 2020.


Leave a Reply

%d bloggers like this: